Skip to content
value.today

Il-Yang Pharmaceutical (South Korea)

007570
No market cap data
Compare
World rank
—
no current market cap
Revenue
—
annual
Net income
—
Employees
—

Il-Yang Pharmaceutical (South Korea) in brief

Il-Yang Pharmaceutical (South Korea) is a listed company in the Healthcare sector, based in Yongin, South Korea. It was founded in 1946. Its shares trade under the symbol 007570 (Korean Stock Exchange).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

Il-Yang Pharmaceutical (South Korea) timeline

2 events, 1946–1974
  1. 1946
  2. 🏁
    Founded
  3. 1974
  4. 🔔
    Initial public offering on Korean Stock Exchange as 007570

Events of Il-Yang Pharmaceutical (South Korea) from Wikidata. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

Not enough history yet.

Mutual funds holding Il-Yang Pharmaceutical (South Korea)#

16 funds hold shares worth $1 M. Since their previous reports 1 added shares and 5 sold, selling $2 M net.
Mutual funds holding Il-Yang Pharmaceutical (South Korea)
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 Emerging Markets Core Equity 2 PortfolioDimensional Fund Advisors LP68,616$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Dimensional Emerging Markets Core Equity 2 ETFDimensional Fund Advisors LP13,193$0 M—<0.01%no changeJul 31, 2026
🇺🇸 The Emerging Markets Small Cap SeriesDimensional Fund Advisors LP9,185$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Avantis Emerging Markets Equity ETFAmerican Century ETF Trust8,045$0 M—<0.01%no changeMay 31, 2026
🇺🇸 State Street SPDR S&P International Small Cap ETFSSGA Funds Management, Inc.8,635$0 M—<0.01%+1.6%Jun 30, 2026
🇺🇸 Dimensional World ex. U.S. Core Equity 2 ETFDimensional Fund Advisors LP7,063$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Dimensional Emerging Markets Value ETFDimensional Fund Advisors LP4,618$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Emerging Markets ex China Core Equity PortfolioDimensional Fund Advisors LP4,169$0 M—<0.01%no changeJul 31, 2026
🇺🇸 World ex U.S. Core Equity PortfolioDimensional Fund Advisors LP3,819$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Emerging Markets Social Core Equity PortfolioDimensional Fund Advisors LP2,889$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Emerging Markets Sustainability Core 1 PortfolioDimensional Fund Advisors LP2,498$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Avantis Emerging Markets Equity FundAmerican Century ETF Trust2,125$0 M—<0.01%no changeMay 31, 2026
🇺🇸 Dimensional Emerging Core Equity Market ETFDimensional Fund Advisors LP1,944$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Emerging Markets Targeted Value PortfolioDimensional Fund Advisors LP1,789$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Dimensional Emerging Markets Sustainability Core 1 ETFDimensional Fund Advisors LP32$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Dimensional Emerging Markets ex China Core Equity ETFDimensional Fund Advisors LP40$0 M—<0.01%no changeJul 31, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 16 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

CompanyMarket capP/ENet marginRev. growth
Il-Yang Pharmaceutical (South Korea)🇰🇷————
Eli Lilly and Company🇺🇸$1.20 T43.4×31.9%+44.7%
Johnson & Johnson🇺🇸$652.5 B40.5×16.2%+6.0%
AbbVie Inc.🇺🇸$514.0 B49.7×15.7%+8.6%
Roche Holding AG🇨🇭$370.3 B29.1×19.0%—
UnitedHealth Group Incorporated🇺🇸$367.7 B23.1×3.5%+11.8%
Merck & Co., Inc.🇺🇸$359.8 B146.7×3.6%+1.3%
Novartis AG🇨🇭$286.8 B20.5×24.7%—
Thermo Fisher Scientific Inc.🇺🇸$253.8 B35.9×14.9%+3.9%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Profile updated:
Nov 15, 2026

Figures from Wikidata, value.today research.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Il-Yang Pharmaceutical (South Korea)? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Il-Yang Pharmaceutical (South Korea)'s ranking on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Il-Yang Pharmaceutical (South Korea)? Suggest a correction